17 alpha-hydroxyprogesterone caproate has been researched along with tamoxifen in 14 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 20,630 | 2,227 | 6,256 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bobrov, JF; Bokhman, JV; Chepick, OF; Shtofmakher, JA; Sofroniy, DF; Tsyrlina, EV; Vishnevsky, AS | 1 |
| Bakhidze, EV | 1 |
| Bokhman, IaV; Chepik, OF; Vishnevskiĭ, AS; Volkova, AT | 1 |
| Iglódi, F | 1 |
| Bobrov, IuF; Bokhman, IaV; Shtofmakher, IA; Tsyrlina, EV; Vishnevskiĭ, AS | 2 |
| Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
| Gerhard, I; Runnebaum, B | 1 |
| Loktionov, AS; Prianishnikov, VA | 1 |
| Loutfi, G; Vishnevsky, AS | 1 |
| Bokhman, IV; Chepik, OF; Ermakova, NA; Maksimov, SI; Mikaia, NA; Nezhentseva, EL; Tsyrlina, EV; Vishnevskiĭ, AS | 1 |
| Cao, B; Zhang, X | 1 |
| Izutsu, T; Sugiyama, T | 1 |
2 review(s) available for 17 alpha-hydroxyprogesterone caproate and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Hormone therapy for uterine corpus cancer--introduction].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Leuprolide; Medroxyprogesterone Acetate; Raloxifene Hydrochloride; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome | 2004 |
2 trial(s) available for 17 alpha-hydroxyprogesterone caproate and tamoxifen
| Article | Year |
|---|---|
Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Survival Rate; Tamoxifen | 1993 |
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Squamous Cell; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen | 1996 |
10 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and tamoxifen
| Article | Year |
|---|---|
Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Cytoplasm; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Middle Aged; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms; Vagina | 1990 |
Application of thymic factor "Thymalin" in complex treatment of endometrial cancer patients.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adjuvants, Immunologic; Antineoplastic Agents; Cells, Cultured; Combined Modality Therapy; Estradiol; Female; Humans; Hydroxyprogesterones; Immunity, Cellular; Middle Aged; Rosette Formation; Survival Rate; T-Lymphocyte Subsets; Tamoxifen; Thymus Hormones; Uterine Neoplasms | 1990 |
[Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone Congeners; Tamoxifen; Uterine Neoplasms | 1990 |
Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents; Breast Neoplasms; Cell Differentiation; Drug Therapy, Combination; Female; Humans; Hydroxyprogesterones; Menopause; Tamoxifen; Testosterone; Vaginal Smears | 1989 |
[The effect of hydroxyprogesterone caproate and its combination with tamoxifen on steroid hormone receptors in the tumor and on the basic parameters of reproductive homeostasis in patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Combined Modality Therapy; Drug Evaluation; Drug Therapy, Combination; Female; Homeostasis; Humans; Hydroxyprogesterones; Middle Aged; Preoperative Care; Progesterone Congeners; Receptors, Estradiol; Receptors, Progesterone; Reproduction; Tamoxifen; Uterine Neoplasms | 1989 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |
[Effects of tamoxifen and oxyprogesterone caproate on steroid hormone receptors in tumors and indicators of reproductive homeostasis in patients with cancer of the uterine body].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Endometrium; Female; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Middle Aged; Prolactin; Receptors, Estradiol; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1988 |
Hormone load tests in the first half of pregnancy--a diagnostic and therapeutic approach.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Abortion, Threatened; Allylestrenol; Betamethasone; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Dehydroepiandrosterone; Endocrine Glands; Estradiol; Female; Hormones; Humans; Hydroxyprogesterones; Peptide Fragments; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Progesterone; Promegestone; Tamoxifen | 1984 |
[Autoradiographic study of hormonal regulation of proliferating golden hamster uterus cells during postnatal ontogeny].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Autoradiography; Cricetinae; Female; Hexestrol; Hydroxyprogesterones; Mesocricetus; Mitotic Index; Tamoxifen; Thymidine; Uterus | 1981 |
[Parameters of estrogen expression in patients with endometrial tumors as prognostic signs of the effectiveness of neoadjuvant antitumor hormone therapy].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Aged; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Endometrial Neoplasms; Estrogen Antagonists; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprogesterones; Middle Aged; Postmenopause; Prognosis; Tamoxifen | 1996 |